Protein-based sample collection matrices and devices

US2017327815A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017327815-A1
Application numberUS-201715592481-A
CountryUS
Kind codeA1
Filing dateMay 11, 2017
Priority dateMay 13, 2016
Publication dateNov 16, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods and compositions to effectively isolate nucleic acids using protein-based sample collection matrices.

First claim

Opening claim text (preview).

We claim: 1 . A kit for isolating nucleic acids from a sample, the kit comprising: a) a protein-based matrix configured to collect sample; b) a solution comprising about 3-6 M chaotrope, about 0.5-10% detergent, about 50-500 mM reducing agent, and buffer maintaining pH of the solution at about 5-8. 2 . The kit of claim 1 , wherein the protein-based matrix forms a swab. 3 . The kit of claim 1 , wherein the protein-based matrix forms a strip to collect liquid sample. 4 . The kit of claim 1 , further comprising processing vessels. 5 . The kit of claim 1 , further comprising filter tubes or magnetic glass beads (MGPs). 6 . The kit of claim 5 , further comprising wash buffer and elution buffer. 7 . The kit of claim 5 , wherein the protein-based matrix is silk. 8 . The kit of claim 5 , wherein the chaotrope is a guanidinium salt. 9 . The kit of claim 5 , wherein the detergent is a non-ionic detergent. 10 . The kit of claim 5 , wherein the reducing agent is dithiothreitol. 11 . The kit of claim 5 , wherein the buffer is a citrate buffer. 12 . The kit of claim 5 , wherein the pH of the solution is 6-7. 13 . The kit of claim 5 , further comprising a container for storing the protein-based matrix and sample. 14 . A method for collecting nucleic acids in a sample, the method comprising contacting a sample containing nucleic acids on a protein-based matrix, thereby collecting nucleic acids. 15 . The method of claim 14 , further comprising placing the protein-based matrix in a container for storage. 16 . The method of claim 14 , further comprising contacting the protein-based matrix with a solution comprising about 3-6 M chaotrope, about 0.5-10% detergent, about 50-500 mM reducing agent, and buffer maintaining pH of the solution at about 5-8, thereby solubilizing the protein-based matrix in the solution. 17 . The method of claim 16 , wherein the protein-based matrix is silk. 18 . The method of claim 16 , wherein the chaotrope is a guanidinium salt. 19 . The method of claim 16 , wherein the detergent is a non-ionic detergent. 20 . The method of claim 16 , wherein the reducing agent is dithiothreitol. 21 . The method of claim 16 , wherein the buffer is a citrate buffer. 22 . The kit of claim 16 , wherein the pH of the solution is 6-7. 23 . The method of claim 16 , wherein the protein-based matrix is immersed in the solution for at least 10 minutes. 24 . The method of claim 16 , further comprising contacting the solution with a filter tube or with magnetic glass beads (MGPs), washing the filter tube or MGPs with wash buffer, and eluting the nucleic acids from the filter tube or MGPs with elution buffer, thereby isolating the nucleic acids from the sample. 25 . The method of claim 16 , wherein the sample is a liquid sample.

Assignees

Inventors

Classifications

  • Sampling from a surface, swabbing, vaporising · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • in the liquid or fluent state {(burettes, pipettes B01L3/02; sampling of ground water E02D1/06; metering by volume of fluids or fluent solid material G01F11/00, G01F13/00)} · CPC title

  • by means of a solid support carrier, e.g. particles, polymers · CPC title

  • Instruments for taking cell samples or for biopsy {(A61B10/0038 and A61B10/0045 take precedence; needle locating or guiding means A61B17/3403; samplers for enzymology or microbiology C12M1/26; sampling or preparing biological specimens G01N33/48)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017327815A1 cover?
Provided herein are methods and compositions to effectively isolate nucleic acids using protein-based sample collection matrices.
Who is the assignee on this patent?
Roche Molecular Systems Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/1006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).